S 355introduced119th Congress

FDA Modernization Act 3.0

Introduced Feb 3, 2025Senate billPolicy area: HealthLast action Dec 17, 2025Sponsor: Cory A. Booker(D-NJ)

healthcareHealth

Health, Education, Labor, and Pensions Committee

Ask about this Build timeline Compare Export source pack

Official Congress record Open in Network Lab Trace connections

Official summaryUpdated Dec 17, 2025

What the bill does

FDA Modernization Act 3.0 This bill requires the Food and Drug Administration (FDA) to publish an interim final rule implementing a provision of the Consolidated Appropriations Act of 2023 that authorized the use of certain alternatives to animal testing to support investigational use of a new drug. The rule must replace references to animal tests, data, studies, models, and research with references to nonclinical tests, data, studies, models, and research throughout the FDA’s regulations governing investigational new drug applications, and may make other changes to the regulations as appropriate. The rule must be published within one year of the bill’s enactment, and must take immediate effect as an interim final rule.

Latest official action

Held at the desk.

Lobbying Filings Citing It

$8.7M

Reported on Those Filings, All Issues

Lobbying Clients

Recorded Votes

Timeline

Feb 3, 2025bill

Bill introduced

Apr 18, 2025lobbying

Lobbying filed by FRAGRANCE CREATORS ASSOCIATION

Jul 17, 2025lobbying

Lobbying filed by CONSUMER HEALTHCARE PRODUCTS ASSOCIATION

Jul 21, 2025lobbying

Lobbying filed by PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

Jul 21, 2025lobbying

Lobbying filed by FRAGRANCE CREATORS ASSOCIATION

Jul 21, 2025lobbying

Official Congressional Actions

Dec 17, 2025Floor

Message on Senate action sent to the House.

View official action

Dec 17, 2025Floor

Received in the House.

View official action

Dec 17, 2025Floor

Held at the desk.

View official action

Dec 16, 2025Discharge

Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.

Health, Education, Labor, and Pensions Committee

View official action

Lobbying Activity

Registrant	Client	Amount	Filed	Period	Issues
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA	PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA	$7.6M	Jul 21, 2025	2025Q2	BUDCPTHCR
FRAGRANCE CREATORS ASSOCIATION	FRAGRANCE CREATORS ASSOCIATION	$210.0K	Apr 18, 2025	2025Q1	CSPCHMTAX

About this page

The lobbying table lists Senate LDA quarterly reports (LD-2) that cite this bill by number and cover a quarter of the 119th Congress. An LD-2 names a bill as “H.R. 1234” with no Congress, so a report on another Congress, which can only concern a different bill with the same number, is left out, even when it was filed after this Congress began. The amount is what the registrant reported for the whole filing, across every issue on it, not spending on this bill. Official actions and the bill summary come from Congress.gov, and votes from the roll-call record. This page no longer pairs the bill with members' stock trades: matching lobbying clients to traded companies by name, and trades to a bill by date, is not something the records establish.